Dr. Mark Stephen Moehle is an assistant professor in the Department of Pharmacology and Therapeutics and the Center for Translational Research in Neurodegeneration at the University of Florida College of Medicine. He undertook postdoctoral training at the Vanderbilt Center for Neuroscience Drug Discovery and earned his PhD from the University of Alabama at Birmingham. Now at the University of Florida, Dr. Moehle and his lab use electrophysiological, behavioral and biochemical techniques to understand the cells, circuits, neurons and synapses that are dysfunctional in movement disorders and that drive the motor and non-motor symptoms of these conditions. The Moehle Lab has a special interest in targeting neuronal proteins called muscarinic acetylcholine receptors to understand the physiology of disease states and to translate these findings into novel therapeutic strategies for movement disorders.
Associated Grants
-
Assessing the Ability of Neuronal Modulators to Treat or Modify the Motor Symptoms of Parkinson’s Disease
2022